Mangoceuticals, Inc. is a biotechnology company focused on developing innovative wellness and lifestyle products that leverage the benefits of natural ingredients. The company specializes in formulating and marketing supplements aimed at enhancing men's health, vitality, and overall quality of life. By combining cutting-edge research with the power of nature, Mangoceuticals aims to provide consumers with effective and safe solutions for improving their well-being, all while promoting a healthier lifestyle. Through its commitment to quality and sustainability, the company seeks to establish itself as a leader in the health and wellness industry. Read More
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer in medical imaging and digital innovation, is redefining the intersection of healthcare technology and decentralized finance through its groundbreaking Thermo Acoustic Enhanced UltraSound (TAEUS®) platform and its newly launched Digital Asset Treasury (DAT) strategy. Together, these initiatives position ENDRA as one of the most forward-looking companies in both the medtech and blockchain arenas.
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
MIAMI, FL / ACCESS Newswire / April 24, 2025 / For decades, the men's health space has remained largely stagnant-held back by legacy brands offering generic solutions and treatment protocols that too often felt like quick fixes rather than genuine care. The result has been an industry shaped by stigma, limited access, and minimal innovation.
DALLAS, TX / ACCESS Newswire / April 22, 2025 / Mangoceuticals Inc. (NASDAQ:MGRX) is on a mission to rewrite the playbook for men's performance, health, and vitality. Its pursuit comes at a time when opportunities have become enormous, with patent expirations on several of the world's most popular health and wellness drugs, opening vast pathways to exploit segmented market opportunities, each worth billions.
